Hi-Q Marine Biotech International, Ltd.   Report issue

For profit Phase 2
Founded: Taipei Taiwan (1998)
Status: No NME R&D (1998)

Organization Overview

First Clinical Trial
2017
NCT03130829
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hi-Q Marine Biotech International, Ltd.

Active Ingredients

Drugs in Phase 2 Trials (1)

oligo fucoidan (3 trials)

Drugs in Other Trials (1)

brown seaweed (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 2